Dov V. Shimon
Chief Executive Officer at Sagax Medical Technologies, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| M. Pauliina Margolis | M | - |
Keystone Heart Ltd.
 Keystone Heart Ltd. Medical SpecialtiesHealth Technology Keystone Heart Ltd. engages in the development and manufacture of cerebral embolic protection devices that aim to reduce the risk of stroke, neurocognitive decline, and dementia caused by brain damage associated with cardiovascular procedures. The company was founded by Dov V. Shimon in 2004 and is headquartered in Caesarea, Israel. | 12 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Shuki Porath | M | - |
Keystone Heart Ltd.
Keystone Heart Ltd. Medical SpecialtiesHealth Technology Keystone Heart Ltd. engages in the development and manufacture of cerebral embolic protection devices that aim to reduce the risk of stroke, neurocognitive decline, and dementia caused by brain damage associated with cardiovascular procedures. The company was founded by Dov V. Shimon in 2004 and is headquartered in Caesarea, Israel. | 5 years |
| Yehuda Kahane | M | 79 |
The Hebrew University of Jerusalem
| 12 years |
| Clive P. Kabatznik | M | 66 |
The Hebrew University of Jerusalem
| 5 years |
| Amir Elstein | M | 67 |
The Hebrew University of Jerusalem
| 6 years |
| Gideon Schurr | M | 71 |
The Hebrew University of Jerusalem
| 6 years |
| Moshe Politi | M | - |
The Hebrew University of Jerusalem
| 4 years |
| Yoav Nardi | M | 79 |
The Hebrew University of Jerusalem
| 6 years |
| Ami Federmann | M | 76 |
The Hebrew University of Jerusalem
| 7 years |
| Miri Medi Ben Yehoshua | F | 69 |
The Hebrew University of Jerusalem
| 7 years |
| Doron Pinhas Birger | M | 73 |
The Hebrew University of Jerusalem
| 5 years |
| Zeev Bronfeld | M | 71 |
The Hebrew University of Jerusalem
| 4 years |
| Lior Buchman | M | - |
Keystone Heart Ltd.
Keystone Heart Ltd. Medical SpecialtiesHealth Technology Keystone Heart Ltd. engages in the development and manufacture of cerebral embolic protection devices that aim to reduce the risk of stroke, neurocognitive decline, and dementia caused by brain damage associated with cardiovascular procedures. The company was founded by Dov V. Shimon in 2004 and is headquartered in Caesarea, Israel. | - |
| Dafna Schwartz | M | 73 |
The Hebrew University of Jerusalem
| 1 years |
| Gavriel David Meron | M | 71 |
The Hebrew University of Jerusalem
| 4 years |
| David Fuchs | M | 75 |
Keystone Heart Ltd.
Keystone Heart Ltd. Medical SpecialtiesHealth Technology Keystone Heart Ltd. engages in the development and manufacture of cerebral embolic protection devices that aim to reduce the risk of stroke, neurocognitive decline, and dementia caused by brain damage associated with cardiovascular procedures. The company was founded by Dov V. Shimon in 2004 and is headquartered in Caesarea, Israel. | - |
| Léo Apotheker | M | 69 |
The Hebrew University of Jerusalem
| 4 years |
| Saul Yedgar | M | 82 |
The Hebrew University of Jerusalem
| 3 years |
| Dina Dublon | F | 70 |
The Hebrew University of Jerusalem
| 3 years |
| Yaakov Stein | M | - |
The Hebrew University of Jerusalem
| 4 years |
| Ehud Arad | M | - |
Keystone Heart Ltd.
Keystone Heart Ltd. Medical SpecialtiesHealth Technology Keystone Heart Ltd. engages in the development and manufacture of cerebral embolic protection devices that aim to reduce the risk of stroke, neurocognitive decline, and dementia caused by brain damage associated with cardiovascular procedures. The company was founded by Dov V. Shimon in 2004 and is headquartered in Caesarea, Israel. | - |
| Yuval Shezifi | M | - |
Keystone Heart Ltd.
Keystone Heart Ltd. Medical SpecialtiesHealth Technology Keystone Heart Ltd. engages in the development and manufacture of cerebral embolic protection devices that aim to reduce the risk of stroke, neurocognitive decline, and dementia caused by brain damage associated with cardiovascular procedures. The company was founded by Dov V. Shimon in 2004 and is headquartered in Caesarea, Israel. | - |
| Baruch Glattstein | M | - |
The Hebrew University of Jerusalem
| 1 years |
| Eli Eliezer Gonen | M | 74 |
The Hebrew University of Jerusalem
| 4 years |
| Reuven Zimlichman | M | 76 |
The Hebrew University of Jerusalem
| 3 years |
| Itamar Raz | M | - |
The Hebrew University of Jerusalem
| 4 years |
| Ben Zeev Yoram | M | 79 |
The Hebrew University of Jerusalem
| 4 years |
| Joseph Shiloah | M | 78 |
The Hebrew University of Jerusalem
| 4 years |
| Angele Anton George Zaboura | M | - |
The Hebrew University of Jerusalem
| 4 years |
| Boaz Laor | M | 72 |
The Hebrew University of Jerusalem
| 4 years |
| Shlomo Mor-Yosef | M | 73 |
The Hebrew University of Jerusalem
| 4 years |
| Elenora Yoeli | F | - |
The Hebrew University of Jerusalem
| 4 years |
| Yossi Rosen | M | - |
The Hebrew University of Jerusalem
| 1 years |
| Dov Ofer | M | 70 |
The Hebrew University of Jerusalem
| 4 years |
| Uri Elmaliach | M | 77 |
The Hebrew University of Jerusalem
| 3 years |
| Eyal Desheh | M | 72 |
The Hebrew University of Jerusalem
| 4 years |
| Paul J. Zalesky | M | - |
Keystone Heart Ltd.
Keystone Heart Ltd. Medical SpecialtiesHealth Technology Keystone Heart Ltd. engages in the development and manufacture of cerebral embolic protection devices that aim to reduce the risk of stroke, neurocognitive decline, and dementia caused by brain damage associated with cardiovascular procedures. The company was founded by Dov V. Shimon in 2004 and is headquartered in Caesarea, Israel. | 1 years |
| Elon Kohlberg | M | 78 |
The Hebrew University of Jerusalem
| 3 years |
| Vince Burgess | M | 59 |
Keystone Heart Ltd.
Keystone Heart Ltd. Medical SpecialtiesHealth Technology Keystone Heart Ltd. engages in the development and manufacture of cerebral embolic protection devices that aim to reduce the risk of stroke, neurocognitive decline, and dementia caused by brain damage associated with cardiovascular procedures. The company was founded by Dov V. Shimon in 2004 and is headquartered in Caesarea, Israel. | 7 years |
| Ben-Zion Weiner | M | 80 |
The Hebrew University of Jerusalem
| 3 years |
| Denis Clive Braham | M | - |
The Hebrew University of Jerusalem
| 4 years |
| Leora Meridor | M | 76 |
The Hebrew University of Jerusalem
| 1 years |
| Hezy Ram | M | - |
The Hebrew University of Jerusalem
| 2 years |
| Elie Savion | M | - |
The Hebrew University of Jerusalem
| 4 years |
| Alfredo Zarowsky | M | - |
The Hebrew University of Jerusalem
| 4 years |
| Morris Mansour | M | 76 |
The Hebrew University of Jerusalem
| 4 years |
| Yaacov Shoham | M | - |
The Hebrew University of Jerusalem
| 6 years |
| Shmuel Peleg | M | - |
The Hebrew University of Jerusalem
| 4 years |
| Ran Goshen | M | - |
The Hebrew University of Jerusalem
| 7 years |
| Jacob Kobi Alexander | M | 72 |
The Hebrew University of Jerusalem
| 4 years |
| Yosi Ben-Dov | M | - |
The Hebrew University of Jerusalem
| 3 years |
| Dan Falk | M | 79 |
The Hebrew University of Jerusalem
| 2 years |
| Raf Hofstein | M | 74 |
The Hebrew University of Jerusalem
| 4 years |
| Tzippora Carmon | F | 71 |
The Hebrew University of Jerusalem
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Israel | 54 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Dov V. Shimon
- Personal Network
